Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women

Jehn Hsiahn Yang, Chin Der Chen, Ming Yih Wu, Kuang Han Chao, Yu Shih Yang, Hong Nerng Ho

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective: To investigate the immunologic deviations of postmenopausal women before and after hormone replacement therapy (HRT). Design: Prospective study. Setting: University teaching hospital.Patient(s): Seventeen postmenopausal women (study group) and 17 women of reproductive age (control group). Intervention(s): Continuous usage of E2 valerate 2 mg/d and medroxyprogesterone acetate 5 mg/d in postmenopausal women in the study group. Main Outcome Measure(s): Immunophenotyping with flow cytometry, cytokine production with and without mitogen stimulation of the peripheral mononuclear cells, and a natural killer (NK) cell cytotoxicity test against K562 target cells by the 51Cr-release assay were performed in the control group and in the study group before, 1 month after, and 6 months after HRT. Result(s): NK cytotoxicity, interferon-γ production, and the T-cell subpopulation were significantly decreased, and the subpopulations of CD3+CD25+ and CD3+HLA-DR+ were increased in the study group before HRT when compared with those in the control group. After HRT was given for 6 months, however, the NK cytotoxicity increased significantly in the postmenopausal women to a value similar to that of the control group. Conclusion(s): Women after menopause are prone to impaired immune responses. Nevertheless, some of the impairment can be restored after HRT. Copyright (C) 2000 American Society for Reproductive Medicine.

Original languageEnglish
Pages (from-to)261-267
Number of pages7
JournalFertility and Sterility
Volume74
Issue number2
DOIs
Publication statusPublished - Aug 1 2000
Externally publishedYes

Fingerprint

CD8-Positive T-Lymphocytes
CD4-Positive T-Lymphocytes
Postmenopause
Interleukin-5
Hormone Replacement Therapy
Menopause
Natural Killer Cells
Interferon-gamma
Interleukin-2
Prospective Studies
T-Lymphocytes
Control Groups
Valerates
Immunophenotyping
Medroxyprogesterone Acetate
K562 Cells
HLA-DR Antigens
Mitogens
Teaching Hospitals
Flow Cytometry

Keywords

  • Hormone replacement therapy
  • Menopause
  • Natural killer cytotoxicity

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women. / Yang, Jehn Hsiahn; Chen, Chin Der; Wu, Ming Yih; Chao, Kuang Han; Yang, Yu Shih; Ho, Hong Nerng.

In: Fertility and Sterility, Vol. 74, No. 2, 01.08.2000, p. 261-267.

Research output: Contribution to journalArticle

@article{eb281c33eb8c4386be7124e1489e9100,
title = "Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women",
abstract = "Objective: To investigate the immunologic deviations of postmenopausal women before and after hormone replacement therapy (HRT). Design: Prospective study. Setting: University teaching hospital.Patient(s): Seventeen postmenopausal women (study group) and 17 women of reproductive age (control group). Intervention(s): Continuous usage of E2 valerate 2 mg/d and medroxyprogesterone acetate 5 mg/d in postmenopausal women in the study group. Main Outcome Measure(s): Immunophenotyping with flow cytometry, cytokine production with and without mitogen stimulation of the peripheral mononuclear cells, and a natural killer (NK) cell cytotoxicity test against K562 target cells by the 51Cr-release assay were performed in the control group and in the study group before, 1 month after, and 6 months after HRT. Result(s): NK cytotoxicity, interferon-γ production, and the T-cell subpopulation were significantly decreased, and the subpopulations of CD3+CD25+ and CD3+HLA-DR+ were increased in the study group before HRT when compared with those in the control group. After HRT was given for 6 months, however, the NK cytotoxicity increased significantly in the postmenopausal women to a value similar to that of the control group. Conclusion(s): Women after menopause are prone to impaired immune responses. Nevertheless, some of the impairment can be restored after HRT. Copyright (C) 2000 American Society for Reproductive Medicine.",
keywords = "Hormone replacement therapy, Menopause, Natural killer cytotoxicity",
author = "Yang, {Jehn Hsiahn} and Chen, {Chin Der} and Wu, {Ming Yih} and Chao, {Kuang Han} and Yang, {Yu Shih} and Ho, {Hong Nerng}",
year = "2000",
month = "8",
day = "1",
doi = "10.1016/S0015-0282(00)00622-1",
language = "English",
volume = "74",
pages = "261--267",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women

AU - Yang, Jehn Hsiahn

AU - Chen, Chin Der

AU - Wu, Ming Yih

AU - Chao, Kuang Han

AU - Yang, Yu Shih

AU - Ho, Hong Nerng

PY - 2000/8/1

Y1 - 2000/8/1

N2 - Objective: To investigate the immunologic deviations of postmenopausal women before and after hormone replacement therapy (HRT). Design: Prospective study. Setting: University teaching hospital.Patient(s): Seventeen postmenopausal women (study group) and 17 women of reproductive age (control group). Intervention(s): Continuous usage of E2 valerate 2 mg/d and medroxyprogesterone acetate 5 mg/d in postmenopausal women in the study group. Main Outcome Measure(s): Immunophenotyping with flow cytometry, cytokine production with and without mitogen stimulation of the peripheral mononuclear cells, and a natural killer (NK) cell cytotoxicity test against K562 target cells by the 51Cr-release assay were performed in the control group and in the study group before, 1 month after, and 6 months after HRT. Result(s): NK cytotoxicity, interferon-γ production, and the T-cell subpopulation were significantly decreased, and the subpopulations of CD3+CD25+ and CD3+HLA-DR+ were increased in the study group before HRT when compared with those in the control group. After HRT was given for 6 months, however, the NK cytotoxicity increased significantly in the postmenopausal women to a value similar to that of the control group. Conclusion(s): Women after menopause are prone to impaired immune responses. Nevertheless, some of the impairment can be restored after HRT. Copyright (C) 2000 American Society for Reproductive Medicine.

AB - Objective: To investigate the immunologic deviations of postmenopausal women before and after hormone replacement therapy (HRT). Design: Prospective study. Setting: University teaching hospital.Patient(s): Seventeen postmenopausal women (study group) and 17 women of reproductive age (control group). Intervention(s): Continuous usage of E2 valerate 2 mg/d and medroxyprogesterone acetate 5 mg/d in postmenopausal women in the study group. Main Outcome Measure(s): Immunophenotyping with flow cytometry, cytokine production with and without mitogen stimulation of the peripheral mononuclear cells, and a natural killer (NK) cell cytotoxicity test against K562 target cells by the 51Cr-release assay were performed in the control group and in the study group before, 1 month after, and 6 months after HRT. Result(s): NK cytotoxicity, interferon-γ production, and the T-cell subpopulation were significantly decreased, and the subpopulations of CD3+CD25+ and CD3+HLA-DR+ were increased in the study group before HRT when compared with those in the control group. After HRT was given for 6 months, however, the NK cytotoxicity increased significantly in the postmenopausal women to a value similar to that of the control group. Conclusion(s): Women after menopause are prone to impaired immune responses. Nevertheless, some of the impairment can be restored after HRT. Copyright (C) 2000 American Society for Reproductive Medicine.

KW - Hormone replacement therapy

KW - Menopause

KW - Natural killer cytotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0034254274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034254274&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(00)00622-1

DO - 10.1016/S0015-0282(00)00622-1

M3 - Article

C2 - 10927042

AN - SCOPUS:0034254274

VL - 74

SP - 261

EP - 267

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -